nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Hyperhidrosis—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Carbidopa—Anorexia—Etoposide—testicular cancer	0.00114	0.00114	CcSEcCtD
Carbidopa—Decreased appetite—Cisplatin—testicular cancer	0.00114	0.00114	CcSEcCtD
Carbidopa—Diarrhoea—Dactinomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00113	0.00113	CcSEcCtD
Carbidopa—Vomiting—Bleomycin—testicular cancer	0.00113	0.00113	CcSEcCtD
Carbidopa—Depression—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Hypotension—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Rash—Bleomycin—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Pain—Cisplatin—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Dermatitis—Bleomycin—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Hypersensitivity—Ifosfamide—testicular cancer	0.00112	0.00112	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Carbidopa—Asthenia—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Carbidopa—Feeling abnormal—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Paraesthesia—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Pruritus—Ifosfamide—testicular cancer	0.00108	0.00108	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Carbidopa—Dyspnoea—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Carbidopa—Somnolence—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Carbidopa—Nausea—Bleomycin—testicular cancer	0.00106	0.00106	CcSEcCtD
Carbidopa—Vomiting—Dactinomycin—testicular cancer	0.00105	0.00105	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Carbidopa—Rash—Dactinomycin—testicular cancer	0.00105	0.00105	CcSEcCtD
Carbidopa—Decreased appetite—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Diarrhoea—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Body temperature increased—Cisplatin—testicular cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Fatigue—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Pain—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Constipation—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Carbidopa—Dizziness—Ifosfamide—testicular cancer	0.00101	0.00101	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—testicular cancer	0.000997	0.000997	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—testicular cancer	0.000992	0.000992	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Carbidopa—Feeling abnormal—Etoposide—testicular cancer	0.00099	0.00099	CcSEcCtD
Carbidopa—Nausea—Dactinomycin—testicular cancer	0.000986	0.000986	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—testicular cancer	0.000985	0.000985	CcSEcCtD
Carbidopa—Gastrointestinal pain—Etoposide—testicular cancer	0.000982	0.000982	CcSEcCtD
Carbidopa—Vomiting—Ifosfamide—testicular cancer	0.000967	0.000967	CcSEcCtD
Carbidopa—Hypersensitivity—Cisplatin—testicular cancer	0.000966	0.000966	CcSEcCtD
Carbidopa—Rash—Ifosfamide—testicular cancer	0.000959	0.000959	CcSEcCtD
Carbidopa—Dermatitis—Ifosfamide—testicular cancer	0.000958	0.000958	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Carbidopa—Urticaria—Etoposide—testicular cancer	0.000954	0.000954	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—testicular cancer	0.000952	0.000952	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—testicular cancer	0.00095	0.00095	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—testicular cancer	0.000949	0.000949	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—testicular cancer	0.000949	0.000949	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—testicular cancer	0.000947	0.000947	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—testicular cancer	0.000943	0.000943	CcSEcCtD
Carbidopa—Asthenia—Cisplatin—testicular cancer	0.00094	0.00094	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—testicular cancer	0.000936	0.000936	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—testicular cancer	0.000911	0.000911	CcSEcCtD
Carbidopa—Nausea—Ifosfamide—testicular cancer	0.000903	0.000903	CcSEcCtD
Carbidopa—Diarrhoea—Cisplatin—testicular cancer	0.000897	0.000897	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—testicular cancer	0.000895	0.000895	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—testicular cancer	0.000887	0.000887	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—testicular cancer	0.000885	0.000885	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—testicular cancer	0.000881	0.000881	CcSEcCtD
Carbidopa—Flushing—Epirubicin—testicular cancer	0.000879	0.000879	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—testicular cancer	0.000879	0.000879	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—testicular cancer	0.000872	0.000872	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—testicular cancer	0.000866	0.000866	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—testicular cancer	0.000863	0.000863	CcSEcCtD
Carbidopa—Asthenia—Etoposide—testicular cancer	0.000862	0.000862	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—testicular cancer	0.000859	0.000859	CcSEcCtD
Carbidopa—Back pain—Methotrexate—testicular cancer	0.000852	0.000852	CcSEcCtD
Carbidopa—Pruritus—Etoposide—testicular cancer	0.00085	0.00085	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—testicular cancer	0.000837	0.000837	CcSEcCtD
Carbidopa—Vomiting—Cisplatin—testicular cancer	0.000833	0.000833	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—testicular cancer	0.000831	0.000831	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—testicular cancer	0.00083	0.00083	CcSEcCtD
Carbidopa—Rash—Cisplatin—testicular cancer	0.000826	0.000826	CcSEcCtD
Carbidopa—Dermatitis—Cisplatin—testicular cancer	0.000826	0.000826	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—testicular cancer	0.000822	0.000822	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—testicular cancer	0.000818	0.000818	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—testicular cancer	0.000815	0.000815	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—testicular cancer	0.000814	0.000814	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—testicular cancer	0.000813	0.000813	CcSEcCtD
Carbidopa—Tension—Epirubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—testicular cancer	0.000801	0.000801	CcSEcCtD
Carbidopa—Back pain—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Carbidopa—Malaise—Methotrexate—testicular cancer	0.000795	0.000795	CcSEcCtD
Carbidopa—Dizziness—Etoposide—testicular cancer	0.000794	0.000794	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—testicular cancer	0.000789	0.000789	CcSEcCtD
Carbidopa—Nausea—Cisplatin—testicular cancer	0.000779	0.000779	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—testicular cancer	0.000775	0.000775	CcSEcCtD
Carbidopa—Cough—Methotrexate—testicular cancer	0.000769	0.000769	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—testicular cancer	0.000768	0.000768	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—testicular cancer	0.000764	0.000764	CcSEcCtD
Carbidopa—Vomiting—Etoposide—testicular cancer	0.000764	0.000764	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Carbidopa—Agitation—Epirubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Carbidopa—Rash—Etoposide—testicular cancer	0.000757	0.000757	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—testicular cancer	0.000756	0.000756	CcSEcCtD
Carbidopa—Headache—Etoposide—testicular cancer	0.000752	0.000752	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—testicular cancer	0.00075	0.00075	CcSEcCtD
Carbidopa—Tension—Doxorubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Carbidopa—Malaise—Epirubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—testicular cancer	0.000741	0.000741	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Carbidopa—Syncope—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—testicular cancer	0.000725	0.000725	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—testicular cancer	0.000725	0.000725	CcSEcCtD
Carbidopa—Cough—Epirubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Carbidopa—Infection—Methotrexate—testicular cancer	0.000715	0.000715	CcSEcCtD
Carbidopa—Nausea—Etoposide—testicular cancer	0.000713	0.000713	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—testicular cancer	0.000712	0.000712	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—testicular cancer	0.000704	0.000704	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—testicular cancer	0.000701	0.000701	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—testicular cancer	0.000688	0.000688	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—testicular cancer	0.000686	0.000686	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Carbidopa—Oedema—Epirubicin—testicular cancer	0.000673	0.000673	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—testicular cancer	0.000672	0.000672	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Carbidopa—Infection—Epirubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Carbidopa—Cough—Doxorubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Carbidopa—Shock—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—testicular cancer	0.000651	0.000651	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—testicular cancer	0.000646	0.000646	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—testicular cancer	0.000641	0.000641	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—testicular cancer	0.000633	0.000633	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—testicular cancer	0.000629	0.000629	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—testicular cancer	0.000625	0.000625	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—testicular cancer	0.000623	0.000623	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000621	0.000621	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—testicular cancer	0.00062	0.00062	CcSEcCtD
Carbidopa—Infection—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Carbidopa—Pain—Methotrexate—testicular cancer	0.000615	0.000615	CcSEcCtD
Carbidopa—Shock—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—testicular cancer	0.000609	0.000609	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—testicular cancer	0.0006	0.0006	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—testicular cancer	0.000593	0.000593	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—testicular cancer	0.000588	0.000588	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—testicular cancer	0.000585	0.000585	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Carbidopa—Pain—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Carbidopa—Constipation—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—testicular cancer	0.000571	0.000571	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—testicular cancer	0.000569	0.000569	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—testicular cancer	0.000569	0.000569	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—testicular cancer	0.000563	0.000563	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—testicular cancer	0.000541	0.000541	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—testicular cancer	0.000537	0.000537	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Carbidopa—Pain—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—testicular cancer	0.00053	0.00053	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—testicular cancer	0.000516	0.000516	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—testicular cancer	0.000509	0.000509	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—testicular cancer	0.000496	0.000496	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—testicular cancer	0.000492	0.000492	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—testicular cancer	0.000476	0.000476	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—testicular cancer	0.000459	0.000459	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—testicular cancer	0.000457	0.000457	CcSEcCtD
Carbidopa—Rash—Methotrexate—testicular cancer	0.000454	0.000454	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—testicular cancer	0.000453	0.000453	CcSEcCtD
Carbidopa—Headache—Methotrexate—testicular cancer	0.000451	0.000451	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—testicular cancer	0.000428	0.000428	CcSEcCtD
Carbidopa—Nausea—Methotrexate—testicular cancer	0.000427	0.000427	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Carbidopa—Rash—Epirubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Carbidopa—Headache—Epirubicin—testicular cancer	0.000422	0.000422	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Carbidopa—Nausea—Epirubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Carbidopa—Rash—Doxorubicin—testicular cancer	0.000393	0.000393	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—testicular cancer	0.000392	0.000392	CcSEcCtD
Carbidopa—Headache—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—testicular cancer	0.00037	0.00037	CcSEcCtD
